Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

The neuropsychological phenotype of Chediak-Higashi disease.

Shirazi TN, Snow J, Ham L, Raglan GB, Wiggs EA, Summers AC, Toro C, Introne WJ.

Orphanet J Rare Dis. 2019 May 6;14(1):101. doi: 10.1186/s13023-019-1049-x.

2.

Functional MRI and direct cortical stimulation: Prediction of postoperative language decline.

Rolinski R, Austermuehle A, Wiggs E, Agrawal S, Sepeta LN, Gaillard WD, Zaghloul KA, Inati SK, Theodore WH.

Epilepsia. 2019 Mar;60(3):560-570. doi: 10.1111/epi.14666. Epub 2019 Feb 11.

PMID:
30740700
3.

fMRI prediction of naming change after adult temporal lobe epilepsy surgery: Activation matters.

You X, Zachery AN, Fanto EJ, Norato G, Germeyan SC, Emery EJ, Sepeta LN, Berl MM, Black CL, Wiggs E, Zaghloul K, Inati SK, Gaillard WD, Theodore WH.

Epilepsia. 2019 Mar;60(3):527-538. doi: 10.1111/epi.14656. Epub 2019 Feb 11.

PMID:
30740666
4.

One-year pilot study on the effects of nitisinone on melanin in patients with OCA-1B.

Adams DR, Menezes S, Jauregui R, Valivullah ZM, Power B, Abraham M, Jeffrey BG, Garced A, Alur RP, Cunningham D, Wiggs E, Merideth MA, Chiang PW, Bernstein S, Ito S, Wakamatsu K, Jack RM, Introne WJ, Gahl WA, Brooks BP.

JCI Insight. 2019 Jan 24;4(2). pii: 124387. doi: 10.1172/jci.insight.124387. [Epub ahead of print]

5.

The Feasibility and Impact of the EMOVE Intervention on Self-efficacy and Outcome Expectations for Exercise in Epilepsy.

Dustin IH, Resnick B, Galik E, Klinedinst NJ, Michael K, Wiggs E, Theodore WH.

J Neurosci Nurs. 2019 Apr;51(2):95-100. doi: 10.1097/JNN.0000000000000425.

PMID:
30649092
6.

In-depth investigations of adolescents and adults with holoprosencephaly identify unique characteristics.

Weiss K, Kruszka P, Guillen Sacoto MJ, Addissie YA, Hadley DW, Hadsall CK, Stokes B, Hu P, Roessler E, Solomon B, Wiggs E, Thurm A, Hufnagel RB, Zein WM, Hahn JS, Stashinko E, Levey E, Baldwin D, Clegg NJ, Delgado MR, Muenke M.

Genet Med. 2018 Jan;20(1):14-23. doi: 10.1038/gim.2017.68. Epub 2017 Jun 22.

7.

Disease progression in C9orf72 mutation carriers.

Floeter MK, Traynor BJ, Farren J, Braun LE, Tierney M, Wiggs EA, Wu T.

Neurology. 2017 Jul 18;89(3):234-241. doi: 10.1212/WNL.0000000000004115. Epub 2017 Jun 14.

8.

Neuropsychological phenotypes of 76 individuals with Joubert syndrome evaluated at a single center.

Summers AC, Snow J, Wiggs E, Liu AG, Toro C, Poretti A, Zein WM, Brooks BP, Parisi MA, Inati S, Doherty D, Vemulapalli M, Mullikin JC; NISC Comparative Sequencing Program, Vilboux T, Gahl WA, Gunay-Aygun M.

Am J Med Genet A. 2017 Jul;173(7):1796-1812. doi: 10.1002/ajmg.a.38272. Epub 2017 May 12.

9.

Reliability and Validity of the Self-Efficacy for Exercise in Epilepsy and the Outcome Expectations for Exercise in Epilepsy Scales.

Dustin I, Resnick B, Galik E, Klinedinst NJ, Michael K, Wiggs E.

J Nurs Meas. 2017 Apr 1;25(1):22-40. doi: 10.1891/1061-3749.25.1.22.

PMID:
28395696
10.

Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72-associated amyotrophic lateral sclerosis.

Gendron TF, Chew J, Stankowski JN, Hayes LR, Zhang YJ, Prudencio M, Carlomagno Y, Daughrity LM, Jansen-West K, Perkerson EA, O'Raw A, Cook C, Pregent L, Belzil V, van Blitterswijk M, Tabassian LJ, Lee CW, Yue M, Tong J, Song Y, Castanedes-Casey M, Rousseau L, Phillips V, Dickson DW, Rademakers R, Fryer JD, Rush BK, Pedraza O, Caputo AM, Desaro P, Palmucci C, Robertson A, Heckman MG, Diehl NN, Wiggs E, Tierney M, Braun L, Farren J, Lacomis D, Ladha S, Fournier CN, McCluskey LF, Elman LB, Toledo JB, McBride JD, Tiloca C, Morelli C, Poletti B, Solca F, Prelle A, Wuu J, Jockel-Balsarotti J, Rigo F, Ambrose C, Datta A, Yang W, Raitcheva D, Antognetti G, McCampbell A, Van Swieten JC, Miller BL, Boxer AL, Brown RH, Bowser R, Miller TM, Trojanowski JQ, Grossman M, Berry JD, Hu WT, Ratti A, Traynor BJ, Disney MD, Benatar M, Silani V, Glass JD, Floeter MK, Rothstein JD, Boylan KB, Petrucelli L.

Sci Transl Med. 2017 Mar 29;9(383). pii: eaai7866. doi: 10.1126/scitranslmed.aai7866.

11.

Biomarkers in a Taurine Trial for Succinic Semialdehyde Dehydrogenase Deficiency.

Schreiber JM, Pearl PL, Dustin I, Wiggs E, Barrios E, Wassermann EM, Gibson KM, Theodore WH.

JIMD Rep. 2016;30:81-87. Epub 2016 Jun 24.

12.

Clinical course and prognosis in patients with Gaucher disease and parkinsonism.

Lopez G, Kim J, Wiggs E, Cintron D, Groden C, Tayebi N, Mistry PK, Pastores GM, Zimran A, Goker-Alpan O, Sidransky E.

Neurol Genet. 2016 Mar 4;2(2):e57. doi: 10.1212/NXG.0000000000000057. eCollection 2016 Apr.

13.

Cystic cerebellar dysplasia and biallelic LAMA1 mutations: a lamininopathy associated with tics, obsessive compulsive traits and myopia due to cell adhesion and migration defects.

Vilboux T, Malicdan MC, Chang YM, Guo J, Zerfas PM, Stephen J, Cullinane AR, Bryant J, Fischer R, Brooks BP, Zein WM, Wiggs EA, Zalewski CK, Poretti A, Bryan MM, Vemulapalli M, Mullikin JC, Kirby M, Anderson SM; NISC Comparative Sequencing Program, Huizing M, Toro C, Gahl WA, Gunay-Aygun M.

J Med Genet. 2016 May;53(5):318-29. doi: 10.1136/jmedgenet-2015-103416. Epub 2016 Jan 13.

PMID:
27095636
14.

MRI/MRS as a surrogate marker for clinical progression in GM1 gangliosidosis.

Regier DS, Kwon HJ, Johnston J, Golas G, Yang S, Wiggs E, Latour Y, Thomas S, Portner C, Adams D, Vezina G, Baker EH, Tifft CJ.

Am J Med Genet A. 2016 Mar;170(3):634-44. doi: 10.1002/ajmg.a.37468. Epub 2015 Dec 8.

PMID:
26646981
15.

Cohort study of neurocognitive functioning and adaptive behaviour in children and adolescents with Niemann-Pick Disease type C1.

Thurm A, Farmer C, Farhat NY, Wiggs E, Black D, Porter FD.

Dev Med Child Neurol. 2016 Mar;58(3):262-9. doi: 10.1111/dmcn.12970. Epub 2015 Nov 19.

16.

Executive Function and Adaptive Behavior in Muenke Syndrome.

Yarnell CM, Addissie YA, Hadley DW, Guillen Sacoto MJ, Agochukwu NB, Hart RA, Wiggs EA, Platte P, Paelecke Y, Collmann H, Schweitzer T, Kruszka P, Muenke M.

J Pediatr. 2015 Aug;167(2):428-34. doi: 10.1016/j.jpeds.2015.04.080. Epub 2015 May 28.

17.

Intrafamilial variability in GMPPB-associated dystroglycanopathy: Broadening of the phenotype.

Bharucha-Goebel DX, Neil E, Donkervoort S, Dastgir J, Wiggs E, Winder TL, Moore SA, Iannaccone ST, Bönnemann CG.

Neurology. 2015 Apr 7;84(14):1495-7. doi: 10.1212/WNL.0000000000001440. Epub 2015 Mar 13. No abstract available.

18.

Taurine trial in succinic semialdehyde dehydrogenase deficiency and elevated CNS GABA.

Pearl PL, Schreiber J, Theodore WH, McCarter R, Barrios ES, Yu J, Wiggs E, He J, Gibson KM.

Neurology. 2014 Mar 18;82(11):940-4. doi: 10.1212/WNL.0000000000000210. Epub 2014 Feb 12.

19.

Cognitive, sensory, and psychosocial characteristics in patients with Bardet-Biedl syndrome.

Brinckman DD, Keppler-Noreuil KM, Blumhorst C, Biesecker LG, Sapp JC, Johnston JJ, Wiggs EA.

Am J Med Genet A. 2013 Dec;161A(12):2964-71. doi: 10.1002/ajmg.a.36245. Epub 2013 Nov 5.

20.

Imaging findings associated with cognitive performance in primary lateral sclerosis and amyotrophic lateral sclerosis.

Meoded A, Kwan JY, Peters TL, Huey ED, Danielian LE, Wiggs E, Morrissette A, Wu T, Russell JW, Bayat E, Grafman J, Floeter MK.

Dement Geriatr Cogn Dis Extra. 2013 Aug 16;3(1):233-50. doi: 10.1159/000353456. eCollection 2013.

21.

Response inhibition in motor conversion disorder.

Voon V, Ekanayake V, Wiggs E, Kranick S, Ameli R, Harrison NA, Hallett M.

Mov Disord. 2013 May;28(5):612-8. doi: 10.1002/mds.25435. Epub 2013 Apr 2.

22.

Auditory analysis of xeroderma pigmentosum 1971-2012: hearing function, sun sensitivity and DNA repair predict neurological degeneration.

Totonchy MB, Tamura D, Pantell MS, Zalewski C, Bradford PT, Merchant SN, Nadol J, Khan SG, Schiffmann R, Pierson TM, Wiggs E, Griffith AJ, DiGiovanna JJ, Kraemer KH, Brewer CC.

Brain. 2013 Jan;136(Pt 1):194-208. doi: 10.1093/brain/aws317.

23.

The neurobiology of glucocerebrosidase-associated parkinsonism: a positron emission tomography study of dopamine synthesis and regional cerebral blood flow.

Goker-Alpan O, Masdeu JC, Kohn PD, Ianni A, Lopez G, Groden C, Chapman MC, Cropp B, Eisenberg DP, Maniwang ED, Davis J, Wiggs E, Sidransky E, Berman KF.

Brain. 2012 Aug;135(Pt 8):2440-8. doi: 10.1093/brain/aws174.

24.

Neurocognitive phenotype of isolated methylmalonic acidemia.

O'Shea CJ, Sloan JL, Wiggs EA, Pao M, Gropman A, Baker EH, Manoli I, Venditti CP, Snow J.

Pediatrics. 2012 Jun;129(6):e1541-51. doi: 10.1542/peds.2011-1715. Epub 2012 May 21.

25.

Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: a cohort study to determine three- and five-year outcomes.

Sibley CH, Plass N, Snow J, Wiggs EA, Brewer CC, King KA, Zalewski C, Kim HJ, Bishop R, Hill S, Paul SM, Kicker P, Phillips Z, Dolan JG, Widemann B, Jayaprakash N, Pucino F, Stone DL, Chapelle D, Snyder C, Butman JA, Wesley R, Goldbach-Mansky R.

Arthritis Rheum. 2012 Jul;64(7):2375-86. doi: 10.1002/art.34409.

26.

Serotonin 1A receptors, depression, and memory in temporal lobe epilepsy.

Theodore WH, Wiggs EA, Martinez AR, Dustin IH, Khan OI, Appel S, Reeves-Tyer P, Sato S.

Epilepsia. 2012 Jan;53(1):129-33. doi: 10.1111/j.1528-1167.2011.03309.x. Epub 2011 Nov 2.

27.

The saccadic and neurological deficits in type 3 Gaucher disease.

Benko W, Ries M, Wiggs EA, Brady RO, Schiffmann R, Fitzgibbon EJ.

PLoS One. 2011;6(7):e22410. doi: 10.1371/journal.pone.0022410. Epub 2011 Jul 20.

28.

Unrelated umbilical cord blood transplant for juvenile metachromatic leukodystrophy: a 5-year follow-up in three affected siblings.

Cable C, Finkel RS, Lehky TJ, Biassou NM, Wiggs EA, Bunin N, Pierson TM.

Mol Genet Metab. 2011 Feb;102(2):207-9. doi: 10.1016/j.ymgme.2010.10.002. Epub 2010 Oct 28.

29.

Temporal lobectomy: resection volume, neuropsychological effects, and seizure outcome.

Shamim S, Wiggs E, Heiss J, Sato S, Liew C, Solomon J, Theodore WH.

Epilepsy Behav. 2009 Oct;16(2):311-4. doi: 10.1016/j.yebeh.2009.07.040. Epub 2009 Aug 22.

30.

Cortical mapping and frameless stereotactic navigation in the high-field intraoperative magnetic resonance imaging suite.

Weingarten DM, Asthagiri AR, Butman JA, Sato S, Wiggs EA, Damaska B, Heiss JD.

J Neurosurg. 2009 Dec;111(6):1185-90. doi: 10.3171/2009.5.JNS09164.

31.

Quality of life in children and adolescents 1-year after cure of Cushing syndrome: a prospective study.

Keil MF, Merke DP, Gandhi R, Wiggs EA, Obunse K, Stratakis CA.

Clin Endocrinol (Oxf). 2009 Sep;71(3):326-33. doi: 10.1111/j.1365-2265.2008.03515.x. Epub 2008 Dec 17.

32.

Altered language processing in autosomal dominant partial epilepsy with auditory features.

Ottman R, Rosenberger L, Bagic A, Kamberakis K, Ritzl EK, Wohlschlager AM, Shamim S, Sato S, Liew C, Gaillard WD, Wiggs E, Berl MM, Reeves-Tyer P, Baker EH, Butman JA, Theodore WH.

Neurology. 2008 Dec 9;71(24):1973-80. doi: 10.1212/01.wnl.0000336923.29538.5b.

33.

XPC initiation codon mutation in xeroderma pigmentosum patients with and without neurological symptoms.

Khan SG, Oh KS, Emmert S, Imoto K, Tamura D, Digiovanna JJ, Shahlavi T, Armstrong N, Baker CC, Neuburg M, Zalewski C, Brewer C, Wiggs E, Schiffmann R, Kraemer KH.

DNA Repair (Amst). 2009 Jan 1;8(1):114-25. doi: 10.1016/j.dnarep.2008.09.007. Epub 2008 Nov 14.

34.

Cognitive outcome in treated patients with chronic neuronopathic Gaucher disease.

Goker-Alpan O, Wiggs EA, Eblan MJ, Benko W, Ziegler SG, Sidransky E, Schiffmann R.

J Pediatr. 2008 Jul;153(1):89-94. doi: 10.1016/j.jpeds.2007.12.023. Epub 2008 Feb 14.

PMID:
18571543
35.

Atypical language in lesional and nonlesional complex partial epilepsy.

Gaillard WD, Berl MM, Moore EN, Ritzl EK, Rosenberger LR, Weinstein SL, Conry JA, Pearl PL, Ritter FF, Sato S, Vezina LG, Vaidya CJ, Wiggs E, Fratalli C, Risse G, Ratner NB, Gioia G, Theodore WH.

Neurology. 2007 Oct 30;69(18):1761-71.

PMID:
17967992
36.

Neuropsychological functioning in adolescent children of mothers with a history of bipolar or major depressive disorders.

Klimes-Dougan B, Ronsaville D, Wiggs EA, Martinez PE.

Biol Psychiatry. 2006 Nov 1;60(9):957-65. Epub 2006 Aug 24.

PMID:
16934765
37.

Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition.

Goldbach-Mansky R, Dailey NJ, Canna SW, Gelabert A, Jones J, Rubin BI, Kim HJ, Brewer C, Zalewski C, Wiggs E, Hill S, Turner ML, Karp BI, Aksentijevich I, Pucino F, Penzak SR, Haverkamp MH, Stein L, Adams BS, Moore TL, Fuhlbrigge RC, Shaham B, Jarvis JN, O'Neil K, Vehe RK, Beitz LO, Gardner G, Hannan WP, Warren RW, Horn W, Cole JL, Paul SM, Hawkins PN, Pham TH, Snyder C, Wesley RA, Hoffmann SC, Holland SM, Butman JA, Kastner DL.

N Engl J Med. 2006 Aug 10;355(6):581-92.

38.

A prospective high-risk study of the association among maternal negativity, apparent frontal lobe dysfunction, and the development of bipolar disorder.

Meyer SE, Carlson GA, Wiggs EA, Ronsaville DS, Martinez PE, Klimes-Dougan B, Gold PW, Radke-Yarrow M.

Dev Psychopathol. 2006 Spring;18(2):573-89.

PMID:
16600068
39.

Children experience cognitive decline despite reversal of brain atrophy one year after resolution of Cushing syndrome.

Merke DP, Giedd JN, Keil MF, Mehlinger SL, Wiggs EA, Holzer S, Rawson E, Vaituzis AC, Stratakis CA, Chrousos GP.

J Clin Endocrinol Metab. 2005 May;90(5):2531-6. Epub 2005 Mar 1.

PMID:
15741254
40.

Hypothalamic hamartomas and seizures: distinct natural history of isolated and Pallister-Hall syndrome cases.

Boudreau EA, Liow K, Frattali CM, Wiggs E, Turner JT, Feuillan P, Sato S, Patsalides A, Patronas N, Biesecker LG, Theodore WH.

Epilepsia. 2005 Jan;46(1):42-7.

41.

Psychiatric and neuropsychological characterization of Pallister-Hall syndrome.

Azzam A, Lerner DM, Peters KF, Wiggs E, Rosenstein DL, Biesecker LG.

Clin Genet. 2005 Jan;67(1):87-92.

PMID:
15617553
42.

A prospective study of the association among impaired executive functioning, childhood attentional problems, and the development of bipolar disorder.

Meyer SE, Carlson GA, Wiggs EA, Martinez PE, Ronsaville DS, Klimes-Dougan B, Gold PW, Radke-Yarrow M.

Dev Psychopathol. 2004 Spring;16(2):461-76.

PMID:
15487606
43.

Cognitive function in patients with chronic granulomatous disease: a preliminary report.

Pao M, Wiggs EA, Anastacio MM, Hyun J, DeCarlo ES, Miller JT, Anderson VL, Malech HL, Gallin JI, Holland SM.

Psychosomatics. 2004 May-Jun;45(3):230-4.

PMID:
15123849
44.

Gonadal mosaicism in severe Pallister-Hall syndrome.

Ng D, Johnston JJ, Turner JT, Boudreau EA, Wiggs EA, Theodore WH, Biesecker LG.

Am J Med Genet A. 2004 Jan 30;124A(3):296-302. Erratum in: Am J Med Genet A. 2005 Jul 15;136(2):225.

PMID:
14708104
45.

The neurogenetics of mucolipidosis type IV.

Altarescu G, Sun M, Moore DF, Smith JA, Wiggs EA, Solomon BI, Patronas NJ, Frei KP, Gupta S, Kaneski CR, Quarrell OW, Slaugenhaupt SA, Goldin E, Schiffmann R.

Neurology. 2002 Aug 13;59(3):306-13.

PMID:
12182165
46.

The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher's disease.

Altarescu G, Hill S, Wiggs E, Jeffries N, Kreps C, Parker CC, Brady RO, Barton NW, Schiffmann R.

J Pediatr. 2001 Apr;138(4):539-47.

PMID:
11295718
47.

Somatosensory evoked potentials as a marker of disease burden in type 3 Gaucher disease.

Garvey MA, Toro C, Goldstein S, Altarescu G, Wiggs EA, Hallett M, Schiffmann R.

Neurology. 2001 Feb 13;56(3):391-4.

PMID:
11171908
48.

Neuropsychological deficits in pediatric patients with childhood-onset schizophrenia and psychotic disorder not otherwise specified.

Kumra S, Wiggs E, Bedwell J, Smith AK, Arling E, Albus K, Hamburger SD, McKenna K, Jacobsen LK, Rapoport JL, Asarnow RF.

Schizophr Res. 2000 Apr 7;42(2):135-44.

PMID:
10742651
49.

Brief report: association of sex chromosome anomalies with childhood-onset psychotic disorders.

Kumra S, Wiggs E, Krasnewich D, Meck J, Smith AC, Bedwell J, Fernandez T, Jacobsen LK, Lenane M, Rapoport JL.

J Am Acad Child Adolesc Psychiatry. 1998 Mar;37(3):292-6.

PMID:
9519634
50.

"Multidimensionally impaired disorder": is it a variant of very early-onset schizophrenia?

Kumra S, Jacobsen LK, Lenane M, Zahn TP, Wiggs E, Alaghband-Rad J, Castellanos FX, Frazier JA, McKenna K, Gordon CT, Smith A, Hamburger S, Rapoport JL.

J Am Acad Child Adolesc Psychiatry. 1998 Jan;37(1):91-9.

PMID:
9444905

Supplemental Content

Support Center